Ratcliffe Liam
- SEC CIK
- 0001547100
No open-market purchases or sales filed in the past year.
Current role at each company
- OKUR OnKure Therapeutics, Inc.Directoras of Aug 11, 2026
- IRON Disc Medicine, Inc.Directoras of Jun 23, 2026
- UPB Upstream Bio, Inc.Directoras of Jun 11, 2026
- CLYM Climb Bio, Inc.Directoras of Jun 28, 2024
- ARVN Arvinas, Inc.Directoras of Jun 21, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Ratcliffe Liam as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ARVN Arvinas, Inc.
Director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2021 (view filing) | Dec 14-16 | 2 days | Ratcliffe LiamDirector | SSale | −355.7K | $67.00 | −$23.8M | −65.7%185.7K after | 8 lots |
| Nov 15, 2021 (view filing) | Nov 10-15 | 5 days | Ratcliffe LiamDirector | SSale | −134.3K | $85.83 | −$11.5M | −19.9%541.4K after | 13 lots |
| Nov 9, 2021 (view filing) | Nov 5 | 4 days | Ratcliffe LiamDirector | SSale | −24.9K | $91.30 | −$2.28M | −100.0%0 after | 6 lots |
| Nov 9, 2021 (view filing) | Nov 5-9 | 4 days | Ratcliffe LiamDirector | SSale | −147.2K | $93.31 | −$13.7M | −17.9%675.7K after | 12 lots |